Comparison between depot and standard release triptoreline in in vitro fertilization: pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results.
OBJECTIVE
To compare the effects of depot and standard release form of triptoreline in superovulation induction in IVF programs.


METHODS
One hundred ninety-six patients undergoing IVF were randomized between two treatment groups. Pituitary desensitization was obtained in group 1 (102 patients) with a single IM injection of 3.75 mg D-Trp-6-luteinizing hormone-releasing hormone (LH-RH) and, in group 2 (94 patients), with daily SC administration of 0.1 mg D-Trp-6-LH-RH. In a subgroup of 11 patients, a series of GnRH tests was performed to investigate pituitary desensitization and, in another subgroup of 12 patients, a study of luteal phase steroid profile was performed. In an additional 23 patients, a series of GnRH tests were performed to investigate pituitary desensitization during the late follicular and midluteal phases.


RESULTS
No differences were found in the time necessary to reach desensitization (11.3 +/- 1.03 versus 11.3 +/- 1.45 days; mean +/- SEM), whereas resumption of pituitary activity takes place in 7 days after the discontinuation of the daily form and in about 2 months after discontinuation of the depot form. No differences were found in the duration of stimulation, number of FSH ampules, E2 levels, and number of follicles (11.7 +/- 0.68, versus 12.2 +/- 0.68) on hCG administration day and the total oocytes collected (9.1 +/- 0.6 versus 9.2 +/- 0.64). Oocyte quality, percentage of fertilization and cleavage, pregnancy rate per transfer (28.7% versus 25.6%), and miscarriages (about 30%) were similar in the two protocols. No difference was found in hormonal levels during the luteal phase. In both groups there was a high incidence of multiple pregnancy.


CONCLUSIONS
Comparable results can be achieved with both long-acting and standard-release forms of GnRH analogs in patients undergoing assisted reproduction in terms of follicular stimulation and abortion rates despite differences in the duration of pituitary suppression.
Porcu
E
E
Department of Reproductive Physiology and Pathology, University of Bologna, Italy.
Dal Prato
L
L
Seracchioli
R
R
Fabbri
R
R
Longhi
M
M
Flamigni
C
C
D000328:Adult; D003338:Corpus Luteum / Q000502:physiology*; D003692:Delayed-Action Preparations; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D008183:Luteal Phase; D010062:Ovulation Induction; D010902:Pituitary Gland / Q000187:drug effects*; D011247:Pregnancy; D011256:Pregnancy Outcome; D013480:Superovulation; D017329:Triptorelin Pamoate / Q000008:administration & dosage* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate